mafenide has been researched along with Disease Models, Animal in 8 studies
Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Large TBSA burns have a deficiency of skin graft donor sites necessitating meshed skin autografts, cultured epithelial autografts or biosynthetic skin substitutes." | 1.30 | The efficacy of 5% Sulfamylon solution for the treatment of contaminated explanted human meshed skin grafts. ( Hill, DP; Ko, F; Maggi, SP; Robson, MC; Smith, PD; Soler, PM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scozzafava, A | 1 |
| Briganti, F | 1 |
| Mincione, G | 1 |
| Menabuoni, L | 1 |
| Mincione, F | 1 |
| Supuran, CT | 1 |
| Han, C | 1 |
| Hu, Q | 1 |
| Yu, A | 1 |
| Jiao, Q | 1 |
| Yang, Y | 1 |
| Barillo, DJ | 1 |
| Croutch, CR | 1 |
| Barillo, AR | 1 |
| Thompson, CK | 1 |
| Roseman, J | 1 |
| Reid, F | 1 |
| Rode, H | 1 |
| de Wet, PM | 1 |
| Davies, MR | 1 |
| Cywes, S | 1 |
| Salisbury, RE | 1 |
| Bevin, AG | 1 |
| Steinkraus, GE | 1 |
| Enterline, DS | 1 |
| Leitch, IO | 1 |
| Kucukcelebi, A | 1 |
| Robson, MC | 2 |
| Maggi, SP | 1 |
| Soler, PM | 1 |
| Smith, PD | 1 |
| Hill, DP | 1 |
| Ko, F | 1 |
| Vistnes, LM | 1 |
| Schmitt, EE | 1 |
| Ksander, GA | 1 |
| Rose, EH | 1 |
| Balkenhol, WJ | 1 |
| Coleman, CL | 1 |
8 other studies available for mafenide and Disease Models, Animal
| Article | Year |
|---|---|
Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane | 1999 |
Mafenide derivatives inhibit neuroinflammation in Alzheimer's disease by regulating pyroptosis.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Biomarkers; Cell Line; Cytokines; Disease Mana | 2021 |
Debridement of Sulfur Mustard Skin Burns: A Comparison of Three Methods.
Topics: Animals; Anti-Bacterial Agents; Bandages; Burns, Chemical; Chemical Warfare Agents; Debridement; Dis | 2020 |
An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
Topics: Administration, Topical; Animals; Burns; Disease Models, Animal; Mafenide; Male; Povidone; Povidone- | 1981 |
Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
Topics: Administration, Topical; Animals; Burns; Cerium; Disease Models, Animal; Mafenide; Pseudomonas Infec | 1980 |
Inhibition of wound contraction by topical antimicrobials.
Topics: Administration, Topical; Aerosols; Animals; Biopsy; Chlorhexidine; Collagen; Disease Models, Animal; | 1993 |
The efficacy of 5% Sulfamylon solution for the treatment of contaminated explanted human meshed skin grafts.
Topics: Animals; Anti-Infective Agents, Local; Burns; Disease Models, Animal; Graft Survival; Humans; Mafeni | 1999 |
Evaluation of a prototype therapeutic system for prolonged, continuous topical delivery of homosulfanilamide in the management of Pseudomonas burn wound sepsis.
Topics: Administration, Topical; Animals; Bandages; Burns; Disease Models, Animal; Mafenide; Male; Ointments | 1976 |